211 related articles for article (PubMed ID: 26797261)
1. Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis.
Calzadilla-Bertot L; Vilar-Gomez E; Torres-Gonzalez A; Socias-Lopez M; Diago M; Adams LA; Romero-Gomez M
Dig Liver Dis; 2016 Mar; 48(3):283-90. PubMed ID: 26797261
[TBL] [Abstract][Full Text] [Related]
2. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
3. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
[TBL] [Abstract][Full Text] [Related]
4. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
[TBL] [Abstract][Full Text] [Related]
5. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).
Trinchet JC; Bourcier V; Chaffaut C; Ait Ahmed M; Allam S; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Buffet C; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Hillaire S; Di Martino V; Nahon P; Chevret S;
Hepatology; 2015 Sep; 62(3):737-50. PubMed ID: 25678021
[TBL] [Abstract][Full Text] [Related]
6. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
7. Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease.
Grancini V; Trombetta M; Lunati ME; Zimbalatti D; Boselli ML; Gatti S; Donato MF; Resi V; D'Ambrosio R; Aghemo A; Pugliese G; Bonadonna RC; Orsi E
J Hepatol; 2015 Dec; 63(6):1484-90. PubMed ID: 26297917
[TBL] [Abstract][Full Text] [Related]
8. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
[TBL] [Abstract][Full Text] [Related]
9. Measurement of Spleen Stiffness With Acoustic Radiation Force Impulse Imaging Predicts Mortality and Hepatic Decompensation in Patients With Liver Cirrhosis.
Takuma Y; Morimoto Y; Takabatake H; Toshikuni N; Tomokuni J; Sahara A; Matsueda K; Yamamoto H
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1782-1790.e4. PubMed ID: 28017842
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
Bruno S; Saibeni S; Bagnardi V; Vandelli C; De Luca M; Felder M; Fracanzani AL; Prisco C; Vitaliani G; Simone L; Gaeta GB; Stanzione M; Persico M; Furlan C; Stroffolini T; Salerno F; Maisonneuve P; Almasio PL;
Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
[TBL] [Abstract][Full Text] [Related]
12. Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents.
Gualerzi A; Bellan M; Smirne C; Tran Minh M; Rigamonti C; Burlone ME; Bonometti R; Bianco S; Re A; Favretto S; Bellomo G; Minisini R; Carnevale Schianca GP; Pirisi M
PLoS One; 2018; 13(12):e0209216. PubMed ID: 30571711
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
[TBL] [Abstract][Full Text] [Related]
14. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Brujats A; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J;
J Hepatol; 2021 Sep; 75(3):589-599. PubMed ID: 33905794
[TBL] [Abstract][Full Text] [Related]
15. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Lo Re V; Zeldow B; Kallan MJ; Tate JP; Carbonari DM; Hennessy S; Kostman JR; Lim JK; Goetz MB; Gross R; Justice AC; Roy JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1172-1181. PubMed ID: 28722244
[TBL] [Abstract][Full Text] [Related]
16. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
Mohanty A; Tate JP; Garcia-Tsao G
Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
18. Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals.
Grint D; Peters L; Rockstroh JK; Rakmanova A; Trofimova T; Lacombe K; Karpov I; Galli M; Domingo P; Kirk O; Lundgren JD; Mocroft A;
AIDS; 2015 Jun; 29(10):1205-15. PubMed ID: 25870984
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
[TBL] [Abstract][Full Text] [Related]
20. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
